カテゴリー： Grand View Research, 世界, 医療/バイオ

HPV検査＆パップテストのグローバル市場2023-2030：子宮頸がん、膣がん

◆英語タイトル：HPV Testing And Pap Test Market Size, Share & Trends Analysis Report By Test Type, By Application (Cervical Cancer, Vaginal Cancer), By Product, By Technology, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが発行した調査報告書（GRV23OCT025）◆商品コード：GRV23OCT025
◆発行会社（リサーチ会社）：Grand View Research
◆発行日：2023年8月
◆ページ数：112
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：臨床診断
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

HPV検査＆パップテスト市場の成長と動向
Grand View Research, Inc.の最新調査によると、世界のHPV検査＆パップテストの市場規模は、2023年から2030年にかけてCAGR 11.8%で成長し、2030年には93億3000万米ドルに達する見込みです。技術の進歩、子宮頸がん検診プログラムの増加、HPV感染率の高さなどが、予測期間中の市場成長を促進すると予想される主な要因です。子宮頸がんは全女性がんの6.6%を占め、低・中所得国の子宮頸がん死亡率ははるかに高くなっています。子宮頸がんは全女性がんの6.6%を占め、低・中所得国の子宮頸がん死亡率は非常に高くなっています。

Globocanの推計によると、2020年には世界で約604,127件の子宮頸がん・子宮体がんが新たに診断され、同年に約341,831人が死亡しました。WHOによると、これらの症例の99％はHPV感染に関連しています。子宮頸がんの罹患率の高さと死亡率の高さは、病気の負担を減らすためにHPV感染検査の需要を高めると予想されます。

検診率を高めるための新しい検査ソリューションやサービスの承認が増加しており、成長をさらに後押しすると予想されます。2020年4月、ロシュはコバス6800/8800システムで使用するコバスHPVスクリーニングのFDA承認を取得しました。さらに、規制機関は技術的に先進的な検査をスクリーニングに推奨しています。例えば、WHOは2021年9月、子宮頸がん予防のためにDNAベースのヒトパピローマウイルス検査を推奨しました。

疾患の有病率が高い地域で規制機関が行っている取り組みは、市場の成長を促進すると予想されます。例えば、Go Further partnership to end AIDS and cervical cancerは、HIVの有病率が高いアフリカ諸国で子宮頸がん検診を提供するイニシアチブです。HIV陽性女性が子宮頸がんを発症する可能性は、他の女性の5倍です。このイニシアチブは、UNAIDS、ブッシュ研究所、メルク社、米国大統領エイズ救済緊急計画による共同作業です。

主な市場プレーヤーには、Abbott; QIAGEN; BD (Becton Dickinson & Company); Quest Diagnostics Incorporated; Hologic Inc.; F. Hoffmann-La Roche Ltd.; Femasys, Inc.; Arbor Vita Corporation; Oncohealth Corporation; and Seegene Inc.などがあります。HPV検査およびパップテスト業界は、複数のローカルプレーヤーによって高度に断片化されています。

HPV検査＆パップテスト市場レポートハイライト

- タイプ別では、検診プログラムの広範な実施に起因して、パップテスト分野が2022年に最大の収益シェアを占めました。

- 技術別では、その他の技術セグメントがHPV検査およびパップテスト業界を支配し、2022年に最大の収益シェアを占めました。

- アプリケーション別では、子宮頸がん検診が2022年に最大の収益シェアを占め、この分野への市場プレイヤーの投資と疾病の高い発生率により、予測期間中に有利なCAGRで成長すると期待されています。

- 消耗品セグメントはHPV検査＆パップテスト業界を支配し、高い使用率により2022年に最大の収益シェアを占めました。

- 最終用途別では、病院・診療所がHPV感染を含むあらゆる疾患の診断と治療のための一次治療の場として機能しているため、病院・診療所分野が2022年にHPV検査＆パップテスト業界を支配しました。

- 地域別では、北米がHPV検査およびパップテスト業界を支配し、2022年に最大の売上シェアを占めました。これは、早期診断に関する高い認識、確立されたスクリーニングガイドライン、有利な医療償還シナリオが同地域の市場成長を促進する要因となっているためです。

第1章. 方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. HPV検査＆パップテスト市場：テストタイプ別分析
第5章. HPV検査＆パップテスト市場：用途別分析
第6章. HPV検査＆パップテスト市場：製品別分析
第7章. HPV検査＆パップテスト市場：技術別分析
第8章. HPV検査＆パップテスト市場：地域別分析
第9章. 競争状況

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Type segment
1.1.1.2. Application segment
1.1.1.3. Technology segment
1.1.1.4. Product segment
1.1.1.5. End-use segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective – 1
1.4.2. Objective – 2
1.4.3. Objective – 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. High incidence of cervical cancer in middle-aged women
3.2.1.2. Increasing number of awareness programs for cervical cancer screening
3.2.1.3. Technological advancements
3.2.2. Market Restraint Analysis
3.2.2.1. A limited number of approved products
3.2.2.2. Changes in regulatory guidelines for cervical cancer screening
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Test Type Business Analysis
4.1. HPV Testing and Pap Test Market: Test Type Movement Analysis
4.2. HPV Testing
4.2.1. HPV Testing Market, 2018 – 2030 (USD Million)
4.3. PAP Testing
4.3.1. PAP Testing Market, 2018 – 2030 (USD Million)
Chapter 5. Source of Application
5.1. HPV Testing and Pap Test Market: Application Movement Analysis
5.2. Cervical Cancer Screening
5.2.1. Cervical Cancer Screening Market, 2018 – 2030 (USD Million)
5.3. Vaginal Cancer Screening
5.3.1. Vaginal Cancer Screening Market, 2018 – 2030 (USD Million)
Chapter 6. Product Business Analysis
6.1. HPV Testing and Pap Test Market: Product Movement Analysis
6.2. Instruments
6.2.1. Instruments Market, 2018 – 2030 (USD Million)
6.3. Consumables
6.3.1. Consumables Market, 2018 – 2030 (USD Million)
6.4. Services
6.4.1. Services Market, 2018 – 2030 (USD Million)
Chapter 7. Technology Business Analysis
7.1. HPV Testing and Pap Test Market: Technology Movement Analysis
7.2. PCR
7.2.1. PCR Market, 2018 – 2030 (USD Million)
7.3. Immunodiagnostics
7.3.1. Immunodiagnostics Market, 2018 – 2030 (USD Million)
7.4. Others
7.4.1. Other Technology Market, 2018 – 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. HPV Testing and Pap Test Market Share By Region, 2022 & 2030
8.2. North America
8.2.1. SWOT Analysis
8.2.2. North America HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.2.3. U.S.
8.2.3.1. Key Country Dynamics
8.2.3.2. Target Disease Prevalence
8.2.3.3. Competitive Scenario
8.2.3.4. Regulatory Framework
8.2.3.5. U.S. HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.2.4. Canada
8.2.4.1. Key Country Dynamics
8.2.4.2. Target Disease Prevalence
8.2.4.3. Competitive Scenario
8.2.4.4. Regulatory Framework
8.2.4.5. Canada HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.3. Europe
8.3.1. SWOT Analysis
8.3.2. Europe HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.3.3. UK
8.3.3.1. Key Country Dynamics
8.3.3.2. Target Disease Prevalence
8.3.3.3. Competitive Scenario
8.3.3.4. Regulatory Framework
8.3.3.5. UK HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.3.4. Germany
8.3.4.1. Key Country Dynamics
8.3.4.2. Target Disease Prevalence
8.3.4.3. Competitive Scenario
8.3.4.4. Regulatory Framework
8.3.4.5. Germany HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.3.5. France
8.3.5.1. Key Country Dynamics
8.3.5.2. Target Disease Prevalence
8.3.5.3. Competitive Scenario
8.3.5.4. Regulatory Framework
8.3.5.5. France HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.3.6. Italy
8.3.6.1. Key Country Dynamics
8.3.6.2. Target Disease Prevalence
8.3.6.3. Competitive Scenario
8.3.6.4. Regulatory Framework
8.3.6.5. Italy HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.3.7. Spain
8.3.7.1. Key Country Dynamics
8.3.7.2. Target Disease Prevalence
8.3.7.3. Competitive Scenario
8.3.7.4. Regulatory Framework
8.3.7.5. Spain HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.3.8. Denmark
8.3.8.1. Key Country Dynamics
8.3.8.2. Target Disease Prevalence
8.3.8.3. Competitive Scenario
8.3.8.4. Regulatory Framework
8.3.8.5. Denmark HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.3.9. Sweden
8.3.9.1. Key Country Dynamics
8.3.9.2. Target Disease Prevalence
8.3.9.3. Competitive Scenario
8.3.9.4. Regulatory Framework
8.3.9.5. Sweden HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.3.10. Norway
8.3.10.1. Key Country Dynamics
8.3.10.2. Target Disease Prevalence
8.3.10.3. Competitive Scenario
8.3.10.4. Regulatory Framework
8.3.10.5. Norway HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.4. Asia Pacific
8.4.1. SWOT Analysis
8.4.2. Asia Pacific HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.4.3. Japan
8.4.3.1. Key Country Dynamics
8.4.3.2. Target Disease Prevalence
8.4.3.3. Competitive Scenario
8.4.3.4. Regulatory Framework
8.4.3.5. Japan HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.4.4. China
8.4.4.1. Key Country Dynamics
8.4.4.2. Target Disease Prevalence
8.4.4.3. Competitive Scenario
8.4.4.4. Regulatory Framework
8.4.4.5. China HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.4.5. India
8.4.5.1. Key Country Dynamics
8.4.5.2. Target Disease Prevalence
8.4.5.3. Competitive Scenario
8.4.5.4. Regulatory Framework
8.4.5.5. India HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.4.6. Australia
8.4.6.1. Key Country Dynamics
8.4.6.2. Target Disease Prevalence
8.4.6.3. Competitive Scenario
8.4.6.4. Regulatory Framework
8.4.6.5. Australia HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Target Disease Prevalence
8.4.7.3. Competitive Scenario
8.4.7.4. Regulatory Framework
8.4.7.5. Thailand HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.4.8. South Korea
8.4.8.1. Key Country Dynamics
8.4.8.2. Target Disease Prevalence
8.4.8.3. Competitive Scenario
8.4.8.4. Regulatory Framework
8.4.8.5. South Korea HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.5. Latin America
8.5.1. SWOT Analysis
8.5.2. Latin America HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.5.3. Brazil
8.5.3.1. Key Country Dynamics
8.5.3.2. Target Disease Prevalence
8.5.3.3. Competitive Scenario
8.5.3.4. Regulatory Framework
8.5.3.5. Brazil HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.5.4. Mexico
8.5.4.1. Key Country Dynamics
8.5.4.2. Target Disease Prevalence
8.5.4.3. Competitive Scenario
8.5.4.4. Regulatory Framework
8.5.4.5. Mexico HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.5.5. Argentina
8.5.5.1. Key Country Dynamics
8.5.5.2. Target Disease Prevalence
8.5.5.3. Competitive Scenario
8.5.5.4. Regulatory Framework
8.5.5.5. Argentina HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.6. MEA
8.6.1. SWOT Analysis
8.6.2. MEA HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.6.3. South Africa
8.6.3.1. Key Country Dynamics
8.6.3.2. Target Disease Prevalence
8.6.3.3. Competitive Scenario
8.6.3.4. Regulatory Framework
8.6.3.5. South Africa HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.6.4. Saudi Arabia
8.6.4.1. Key Country Dynamics
8.6.4.2. Target Disease Prevalence
8.6.4.3. Competitive Scenario
8.6.4.4. Regulatory Framework
8.6.4.5. Saudi Arabia HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.6.5. UAE
8.6.5.1. Key Country Dynamics
8.6.5.2. Target Disease Prevalence
8.6.5.3. Competitive Scenario
8.6.5.4. Regulatory Framework
8.6.5.5. UAE HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
8.6.6. Kuwait
8.6.6.1. Key Country Dynamics
8.6.6.2. Target Disease Prevalence
8.6.6.3. Competitive Scenario
8.6.6.4. Regulatory Framework
8.6.6.5. Kuwait HPV Testing and Pap Test Market, 2018 – 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2022
9.4. Company Profiles/Listing
9.4.1. Abbott
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. QIAGEN
9.4.2.1. Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. BD
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Hologic, Inc.
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. F. Hoffmann-La Roche Ltd
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. Femasys, Inc.
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Arbor Vita Corporation
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. NURX, Inc.
9.4.8.1. Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Seegene Inc.
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Thermo Fisher Scientific, Inc.
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives
9.4.11. Biomérieux
9.4.11.1. Overview
9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.11.3. Product Benchmarking
9.4.11.4. Strategic Initiatives

List of Tables

Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies/technology disruptors/innovators
Table 3 North America HPV Testing and Pap Test market, by country, 2018 - 2030 (USD Million)
Table 4 North America HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 5 North America HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 6 North America HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 7 North America HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 8 North America HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 9 U.S. HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 10 U.S. HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 11 U.S. HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 12 U.S. HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 13 U.S. HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 14 Canada HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 15 Canada HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 16 Canada HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 17 Canada HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 18 Canada HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 19 Europe HPV Testing and Pap Test market, by country, 2018 - 2030 (USD Million)
Table 20 Europe HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 21 Europe HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 22 Europe HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 23 Europe HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 24 Europe HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 25 Germany HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 26 Germany HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 27 Germany HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 28 Germany HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 29 Germany HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 30 UK HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 31 UK HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 32 UK HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 33 UK HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 34 UK HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 35 France HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 36 France HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 37 France HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 38 France HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 39 France HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 40 Spain HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 41 Spain HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 42 Spain HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 43 Spain HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 44 Spain HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 45 Italy HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 46 Italy HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 47 Italy HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 48 Italy HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 49 Italy HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 50 Denmark HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 51 Denmark HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 52 Denmark HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 53 Denmark HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 54 Denmark HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 55 Sweden HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 56 Sweden HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 57 Sweden HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 58 Sweden HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 59 Sweden HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 60 Norway HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 61 Norway HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 62 Norway HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 63 Norway HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 64 Norway HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 65 Asia Pacific HPV Testing and Pap Test market, by country, 2018 - 2030 (USD Million)
Table 66 Asia Pacific HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 67 Asia Pacific HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 68 Asia Pacific HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 69 Asia Pacific HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 70 Asia Pacific HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 71 Japan HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 72 Japan HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 73 Japan HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 74 Japan HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 75 Japan HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 76 China HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 77 China HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 78 China HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 79 China HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 80 China HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 81 India HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 82 India HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 83 India HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 84 India HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 85 India HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 86 South Korea HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 87 South Korea HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 88 South Korea HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 89 South Korea HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 90 South Korea HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 91 Thailand HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 92 Thailand HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 93 Thailand HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 94 Thailand HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 95 Thailand HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 96 Australia HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 97 Australia HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 98 Australia HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 99 Australia HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 100 Australia HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 101 Latin America HPV Testing and Pap Test market, by country, 2018 - 2030 (USD Million)
Table 102 Latin America HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 103 Latin America HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 104 Latin America HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 105 Latin America HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 106 Latin America HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 107 Brazil HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 108 Brazil HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 109 Brazil HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 110 Brazil HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 111 Brazil HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 112 Mexico HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 113 Mexico HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 114 Mexico HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 115 Mexico HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 116 Mexico HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 117 Argentina HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 118 Argentina HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 119 Argentina HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 120 Argentina HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 121 Argentina HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 122 MEA HPV Testing and Pap Test market, by country, 2018 - 2030 (USD Million)
Table 123 MEA HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 124 MEA HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 125 MEA HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 126 MEA HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 127 MEA HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 128 South Africa HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 129 South Africa HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 130 South Africa HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 131 South Africa HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 132 South Africa HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 133 Saudi Arabia HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 134 Saudi Arabia HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 135 Saudi Arabia HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 136 Saudi Arabia HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 137 Saudi Arabia HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 138 UAE HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 139 UAE HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 140 UAE HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 141 UAE HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 142 UAE HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)
Table 143 Kuwait HPV Testing and Pap Test Market, by Test Type, 2018 - 2030 (USD Million)
Table 144 Kuwait HPV Testing and Pap Test Market, by Product, 2018 - 2030 (USD Million)
Table 145 Kuwait HPV Testing and Pap Test Market, by Technology, 2018 - 2030 (USD Million)
Table 146 Kuwait HPV Testing and Pap Test Market, by Application, 2018 - 2030 (USD Million)
Table 147 Kuwait HPV Testing and Pap Test market, by end-use, 2018 - 2030 (USD Million)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ HPV検査＆パップテストのグローバル市場2023-2030：子宮頸がん、膣がん(HPV Testing And Pap Test Market Size, Share & Trends Analysis Report By Test Type, By Application (Cervical Cancer, Vaginal Cancer), By Product, By Technology, By End-use, By Region, And Segment Forecasts, 2023 - 2030)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • HPV検査＆パップテストのグローバル市場2023-2030：子宮頸がん、膣がん
  • 血液検査のグローバル市場2023-2030：ブドウ糖、脂質、新型コロナウイルス感染症、A1C、CRP、ビタミンD、ALT、AST、甲状腺刺激ホルモン、PSA、コルチゾール
  • 血液検査のグローバル市場2023-2030：ブドウ糖、脂質、新型コロナウイルス感染症、A1C、CRP、ビタミンD、ALT、AST、甲状腺刺激ホルモン、PSA、コルチゾール
  • 産業用微生物試験サービスのグローバル市場2023-2030：無菌性試験、微生物限界試験
  • 産業用微生物試験サービスのグローバル市場2023-2030：無菌性試験、微生物限度試験

    • ◆H&Iグローバルリサーチのお客様（例）◆